Evidence map›Paper›PMID 24883303›Full record

ArticleBioMed research international2014

Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis,  Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.

Georgia Levidou, Sotirios Sachanas, Gerassimos A Pangalis, Christina Kalpadakis, Xanthi Yiakoumis, Maria Moschogiannis, Athanasia Sepsa, Eleftheria Lakiotaki, Vassilis Milionis, Marie-Christine Kyrtsonis and 11 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Serum Interleukin 6 (IL -6) as Prognostic Marker in Egyptian CLL patients.International journal of hematology-oncology and stem cell research · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Georgia LevidouFirst Department of Pathology, Laikon Hospital, University of Athens, Medical School, 75 Mikras Asias street, 11527 Athens, Greece.ORCID 0000-0002-1398-178X
Sotirios SachanasAthens Medical Center-Psychicon Branch, 15451 Athens, Greece.ORCID 0000-0003-4818-8033
Gerassimos A PangalisAthens Medical Center-Psychicon Branch, 15451 Athens, Greece.
Christina KalpadakisHematology Department, University of Crete, 70013 Heraklion, Greece.
Xanthi YiakoumisAthens Medical Center-Psychicon Branch, 15451 Athens, Greece.
Maria MoschogiannisAthens Medical Center-Psychicon Branch, 15451 Athens, Greece.
Athanasia SepsaFirst Department of Pathology, Laikon Hospital, University of Athens, Medical School, 75 Mikras Asias street, 11527 Athens, Greece.
Eleftheria LakiotakiFirst Department of Pathology, Laikon Hospital, University of Athens, Medical School, 75 Mikras Asias street, 11527 Athens, Greece.
Vassilis MilionisFirst Department of Pathology, Laikon Hospital, University of Athens, Medical School, 75 Mikras Asias street, 11527 Athens, Greece.
Marie-Christine KyrtsonisHematology Department, University of Athens, Laikon General Hospital, 11527 Athens, Greece.ORCID 0000-0001-9805-9112
Theodoros P VassilakopoulosHematology Department, University of Athens, Laikon General Hospital, 11527 Athens, Greece.
Pantelis TsirkinidisAthens Medical Center-Psychicon Branch, 15451 Athens, Greece.
Flora KontopidouHematology Department, University of Athens, Ipokration General Hospital, 11527 Athens, Greece.
Styliani KokorisHematology Department, University of Athens, Attikon General Hospital, 12461 Athens, Greece.
Marina SiakantarisFirst Department of Internal Medicine, University of Athens, Laikon General Hospital, 11527 Athens, Greece.
Maria AngelopoulouHematology Department, University of Athens, Laikon General Hospital, 11527 Athens, Greece.
Helen PapadakiHematology Department, University of Crete, 70013 Heraklion, Greece.
Nikolaos KavantzasFirst Department of Pathology, Laikon Hospital, University of Athens, Medical School, 75 Mikras Asias street, 11527 Athens, Greece.
Panayiotis PanayiotidisHematology Department, University of Athens, Laikon General Hospital, 11527 Athens, Greece.
Efstratios PatsourisFirst Department of Pathology, Laikon Hospital, University of Athens, Medical School, 75 Mikras Asias street, 11527 Athens, Greece.
Penelope KorkolopoulouFirst Department of Pathology, Laikon Hospital, University of Athens, Medical School, 75 Mikras Asias street, 11527 Athens, Greece.
National and Kapodistrian University of Athens · GRAthens Medical Center · GRUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of studies have looked into the pathophysiological role of angiogenesis in CLL, but the results have often been inconsistent. We aimed to gain direct insight into the angiogenic process in lymph nodes involved by CLL, focusing on proangiogenic cytokines and microvessel morphometry. The tissue levels of VEGF, Th-2 cytokines IL-6 and IL-8, IL-8 receptor CXCR2, and tyrosine p-STAT-3/SOCS-3 axis modulating cytokine expression were evaluated immunohistochemically in 62 CLL/SLL cases. Microvascular characteristics were evaluated by image analysis. Results were analyzed with regard to clinicopathological characteristics. Proliferation centers (PCs) were less well vascularised compared to non-PC areas. IL-8 and CXCR2 expression was distinctly uncommon as opposed to IL-6, VEGF and SOCS-3, which were detected in the vast majority of cases. The latter two molecule expressions were more pronounced in the PCs in ∼ 40% of the cases. p-STAT-3 immunoreactivity was recorded in 66.67% of the cases with a predilection for PCs. Microvessel morphometry was unrelated to proangiogenic cytokines, p-STAT-3, SOCS-3, or survival. Microvascular caliber and VEGF expression were higher in Binet stage A, whereas IL-6 expression was higher in stage C. VEGF and p-STAT-3 exerted a favorable effect on progression, which remained significant in multivariate analysis, thereby constituting potential outcome predictors in CLL patients.

Indexed as

AdultAgedCell ProliferationDisease-Free SurvivalFemaleGene Expression Regulation, NeoplasticHumansInterleukin-6Interleukin-8Leukemia, Lymphocytic, Chronic, B-CellLymph NodesMaleMiddle AgedNeovascularization, PathologicPrognosisReceptors, Interleukin-8BIL6 protein, humanInterleukin-6Interleukin-8Receptors, Interleukin-8BSOCS3 protein, humanSTAT3 protein, humanSTAT3 Transcription FactorSuppressor of Cytokine Signaling 3 ProteinSuppressor of Cytokine Signaling ProteinsVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID24883303
PMCPMC4026921
OpenAlexW2029757195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.